MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
common stock-Atm...
$3,751K
Proceeds from issuance of
series b convertible...
$1,170K
Proceeds from issuance of
convertible notes payable
$300K
Proceeds from notes
payable due to related...
$300K
Proceeds from the sale of
trading debt securities
$300K
Proceeds from short-term
notes payable
$61K
Net cash provided by
financing activities
$5,344K
Net cash provided by
(used in) investing...
$167K
Canceled cashflow
$238K
Canceled cashflow
$133K
Net change in cash
and cash...
-$2,785K
Canceled cashflow
$5,511K
Loss on impairment of
intangible assets
$6,995K
Loss on debt
extinguishment
-$3,260K
Depreciation and
amortization
$2,115K
Acquired in-process
research and development
$1,967K
Accounts payable
$1,156K
Net loss on trading
debt securities
-$564K
Stock-based compensation
$338K
Prepaid expenses and
other current assets
-$255K
Interest
payable-Related Party
$185K
Accrued expenses
$149K
Amortization of discount on
note payable
$45K
Interest
payable-Variable Interest Entity...
$39K
Current portion of
royalties payable due to...
$19K
Payments on short-term
notes payable
$238K
Consideration paid for the
acquired in-process...
$116K
Purchases of property and
equipment
$17K
Net cash used in
operating activities
-$8,296K
Canceled cashflow
$17,087K
Net loss
-$17,695K
Change in fair value of
royalties payable due to...
$5,709K
Deferred income tax
provision (benefit)
-$1,810K
Accounts receivable
$85K
Inventories
$78K
Operating lease
right-of-use assets and lease...
-$4K
Change in fair value of
convertible notes payable
$2K
Back
Back
Cash Flow
source: myfinsight.com
Catheter Precision, Inc. (VTAK)
Catheter Precision, Inc. (VTAK)